Impact of Implementation of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast
Latest Information Update: 29 Oct 2022
At a glance
- Drugs Emicizumab (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
Most Recent Events
- 24 Oct 2022 Status changed from recruiting to completed.
- 03 May 2022 Planned primary completion date changed from 1 Apr 2022 to 1 Jul 2022.
- 18 Mar 2022 New trial record